Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've searched for semaglutide and dogs together, you're probably not a vet — you're a person wondering whether a human weight-loss medicine could help a pet, or perhaps you've heard the name and wanted to understand what it actually is. Semaglutide is a prescription medicine licensed in the UK for weight management and type 2 diabetes in humans; it has no licensed veterinary application in the UK, and giving human prescription medicines to animals without a vet's direction carries real risks. This page explains what semaglutide is, why it ends up in pet-related searches, and what options exist if either you or a loved one is looking for weight-loss support.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Search data shows that "semaglutide dogs" spikes whenever GLP-1 medicines get heavy news coverage. People are curious. Some have dogs who are overweight and are wondering whether the same science applies. Others have stumbled across the brand name and simply want to understand what it does before their own consultation. A smaller group are worried they've read something alarming about dogs and a medicine in the news.
All of those are fair reasons to search. The clear answer is this: semaglutide (whether as the weight-management injection Wegovy or the diabetes medicine Ozempic) is authorised by the MHRA for use in adult humans only. No veterinary formulation is licensed in the UK. The mechanisms of semaglutide involve GLP-1 receptor pathways that exist across many species, which is why the curiosity makes biological sense, but the leap from scientific plausibility to clinical safety in a specific animal species requires years of species-specific study that simply hasn't happened for dogs in an approved product.
Giving a human prescription medicine to a dog without a vet's supervision isn't a grey area, it's genuinely risky. Doses that are calibrated for a 90kg human mean something entirely different for a 10kg spaniel, and pen-format delivery systems aren't designed with animal physiology in mind. If your dog is struggling with weight, the right conversation is with your vet, who can assess whether a diet plan, a prescription veterinary diet, or another licensed intervention is appropriate. You can read more about the specific question of Wegovy and dogs on a dedicated page.
Semaglutide works by mimicking a gut hormone called GLP-1, which is released after eating. It slows the rate at which the stomach empties, reduces appetite signals in the brain, and affects blood sugar regulation. In practice, people taking it typically feel fuller on smaller amounts of food and find that the background mental noise around eating quietens down. That effect has made it one of the most discussed medicines of the past decade.
For weight management in adults, it's prescribed as Wegovy, a once-weekly subcutaneous injection with a titration schedule that starts at 0.25mg and works up to a maintenance dose over several months, and our semaglutide 1mg guide covers what that particular dose stage involves in more detail. The clinical background on semaglutide covers its development and the evidence base in more detail. The STEP 1 trial, published in the New England Journal of Medicine, showed an average weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose in adults with obesity. Results in the real world vary; a prescriber assesses the full picture before recommending any dose.
Semaglutide is a prescription-only medicine in the UK. That means a qualified prescriber has to assess each person individually, consider their medical history and any medicines they take, and decide whether it's appropriate. There are no shortcuts to that process, and a legitimate pharmacy will never supply it without one.
Because semaglutide is widely searched, it's also widely counterfeited. The MHRA has issued repeated warnings about fake pens sold via social media, often without any clinical assessment, at prices designed to look attractive. Some seized products contained insulin instead of semaglutide, a potentially life-threatening substitution. You can report a suspect seller via the Yellow Card scheme, which the MHRA uses to track unsafe products and take enforcement action.
Verifying a pharmacy before you use it is straightforward. The GPhC register lists every registered pharmacy in Great Britain; a legitimate online pharmacy will have a GPhC premises registration number displayed on its site and you can cross-check it in seconds. If a seller doesn't display that number, or if the price looks disconnected from the real market, treat it as a red flag.
For a broader picture of the weight-loss treatment options available in the UK, including how Wegovy compares to other licensed medicines, the treatment overview page is a useful starting point. Pricing context, including how costs vary by dose and provider, is covered on the Wegovy price comparison page.
Sometimes a search that starts with a pet ends somewhere personal. If you're at the point of wondering whether semaglutide might be right for you, that's a question worth answering properly. The NHS page on semaglutide covers what it's used for, common side effects and who it isn't suitable for, a good first read before any consultation.
At nume, every consultation is read by a GPhC-registered Independent Prescriber (a real clinician, not software) usually on the day you submit it. The process includes identity and weight verification, a review of your medical history, and GP notification in line with GPhC guidance. If you're clinically suitable, treatment is dispatched the same day for free next-working-day delivery. If you'd like to see whether you meet the clinical criteria, you can check your eligibility through a free consultation, there's no obligation and no hidden charge.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.